LENZ Therapeutics, Inc.·4

Nov 10, 4:13 PM ET

MCCOLLUM JAMES W 4

4 · LENZ Therapeutics, Inc. · Filed Nov 10, 2025

Insider Transaction Report

Form 4
Period: 2025-11-07
Transactions
  • Purchase

    Common Stock

    2025-11-07$22.79/sh+10,500$239,27810,500 total
Holdings
  • Common Stock

    (indirect: By Trust)
    620,599
Footnotes (2)
  • [F1]Represents the weighted average share price of an aggregate total of 10,500 shares purchased in the price range of $22.68 to $22.87 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  • [F2]Includes 95,034 shares transferred by the Reporting Person to the McCollum Living Trust on June 6, 2024.

Documents

1 file
  • 4
    wk-form4_1762809230.xmlPrimary

    FORM 4